Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Consumer Cyclical Healthcare Advertising Agencies Biotechnology
Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc. > What is the reason
View:
Post by amendis on Jul 13, 2021 10:48pm

What is the reason

What is the reason Ifonprodi drop out 3 phase. what FDA said its not worth to go? 30 years go ONE coo said FDA not treat Canadian companies not treat fairly. NO death find in and doctors said drug is good. Why FDA comment release to share holders.
Comment by BlaineBorg on Jul 14, 2021 8:08am
Agreed. Release The FDA's "OFFICIAL MEETING MINUTES" to ALL shareholders ASAP. There is zero reason to blindly trust what the CEO claims in the news release. Demand respect and demand proof now. Get active you passive pennyland shareholders. BB
Comment by Flyer47 on Jul 15, 2021 7:55pm
Agreed, he needs to relese the meeting minutes to show a minimum of good faith. Otherwise we can not return to tusting him.
Comment by BlaineBorg on Jul 15, 2021 11:40pm
Christopher Moreau, the CEO is in bed with Kulwant Malhi. The #1 common shareholder and institutional investors of Algernon stock. He has gone to work for Kulwant Malhi at First Responder Technologies before it's complete meltdown. The CEO also chose to create a conflict of interest by appointing the BioPub owner (Dr. KSS) to the advisory board. In that capacity the CEO has held at least 1 ...more  
Comment by BlaineBorg on Jul 19, 2021 2:36pm
This post has been removed in accordance with Community Policy
Algernon Pharmaceuticals Inc.